Prophylaxis for venous thromboembolism in total hip arthroplasty: a review.
O'Meara
P M
PM
Department of Orthopedics, St. Francis Regional Medical Center, Wichita, KS 67214.
Kaufman
E E
EE
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001458:Bandages; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D003911:Dextrans; D004338:Drug Combinations; D006495:Heparin, Low-Molecular-Weight; C031388:heparin-dihydergot; D004087:Dihydroergotamine; D014859:Warfarin; D006493:Heparin; D001241:Aspirin